SLC25A33
gene geneOn this page
Also known as MGC4399BMSC-MCPPNC1
Summary
SLC25A33 (solute carrier family 25 member 33, HGNC:29681) is a protein-coding gene on chromosome 1p36.22, encoding Solute carrier family 25 member 33 (Q9BSK2). Mitochondrial transporter that imports/exports pyrimidine nucleotides into and from mitochondria.
SLC25A33 belongs to the SLC25 family of mitochondrial carrier proteins (Haitina et al., 2006 [PubMed 16949250]).
Source: NCBI Gene 84275 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 56 total
- MANE Select transcript:
NM_032315
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29681 |
| Approved symbol | SLC25A33 |
| Name | solute carrier family 25 member 33 |
| Location | 1p36.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC4399, BMSC-MCP, PNC1 |
| Ensembl gene | ENSG00000171612 |
| Ensembl biotype | protein_coding |
| OMIM | 610816 |
| Entrez | 84275 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
ENST00000302692, ENST00000891097, ENST00000891098, ENST00000891099, ENST00000891100, ENST00000891101, ENST00000958030
RefSeq mRNA: 1 — MANE Select: NM_032315
NM_032315
CCDS: CCDS103
Canonical transcript exons
ENST00000302692 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001149679 | 9579954 | 9580234 |
| ENSE00001149696 | 9573346 | 9573412 |
| ENSE00001149707 | 9570258 | 9570358 |
| ENSE00001180822 | 9567284 | 9567361 |
| ENSE00001307331 | 9582299 | 9585173 |
| ENSE00001312669 | 9553626 | 9553805 |
| ENSE00001312767 | 9539465 | 9539747 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 83.47.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.5142 / max 251.2474, expressed in 1781 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 518 | 5.9009 | 1731 |
| 519 | 4.6133 | 1489 |
Top tissues by expression
141 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| putamen | UBERON:0001874 | 83.47 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 83.43 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.17 | gold quality |
| gastrocnemius | UBERON:0001388 | 83.14 | gold quality |
| thymus | UBERON:0002370 | 82.98 | silver quality |
| substantia nigra | UBERON:0002038 | 82.75 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.73 | gold quality |
| hypothalamus | UBERON:0001898 | 82.10 | gold quality |
| muscle of leg | UBERON:0001383 | 81.70 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 81.12 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 80.50 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 80.47 | gold quality |
| spinal cord | UBERON:0002240 | 80.29 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 80.25 | gold quality |
| prefrontal cortex | UBERON:0000451 | 80.19 | gold quality |
| islet of Langerhans | UBERON:0000006 | 79.95 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 79.95 | gold quality |
| frontal cortex | UBERON:0001870 | 79.93 | gold quality |
| right frontal lobe | UBERON:0002810 | 79.93 | gold quality |
| cerebral cortex | UBERON:0000956 | 79.78 | gold quality |
| amygdala | UBERON:0001876 | 79.73 | gold quality |
| temporal lobe | UBERON:0001871 | 79.72 | gold quality |
| nucleus accumbens | UBERON:0001882 | 79.09 | gold quality |
| primary visual cortex | UBERON:0002436 | 78.99 | gold quality |
| right testis | UBERON:0004534 | 78.79 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.69 | gold quality |
| testis | UBERON:0000473 | 78.60 | gold quality |
| left testis | UBERON:0004533 | 78.55 | gold quality |
| Ammon’s horn | UBERON:0001954 | 78.25 | gold quality |
| brain | UBERON:0000955 | 78.02 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
45 targeting SLC25A33, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-4804-3P | 99.65 | 67.78 | 866 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
Literature-anchored findings (GeneRIF, showing 4)
- BMSC-MCP is a phylogenetically conserved and widely expressed mitochondrial carrier protein which perhaps associates with mitochondrial oxidative phosphorylation (PMID:14715278)
- PNC1 is essential for mitochondria maintenance. (PMID:20453889)
- Compares and contrasts all the known human SLC25A* genes and includes functional information. (PMID:23266187)
- The main physiological role of SLC25A33 and SLC25A36 is to import/export pyrimidine nucleotides into and from mitochondria (PMID:25320081)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc25a33 | ENSDARG00000039931 |
| mus_musculus | Slc25a33 | ENSMUSG00000028982 |
| rattus_norvegicus | Slc25a33 | ENSRNOG00000016949 |
Paralogs (49): SLC25A13 (ENSG00000004864), SLC25A5 (ENSG00000005022), SLC25A39 (ENSG00000013306), SLC25A40 (ENSG00000075303), SLC25A3 (ENSG00000075415), SLC25A43 (ENSG00000077713), SLC25A24 (ENSG00000085491), SLC25A1 (ENSG00000100075), SLC25A17 (ENSG00000100372), SLC25A14 (ENSG00000102078), SLC25A15 (ENSG00000102743), SLC25A11 (ENSG00000108528), UCP1 (ENSG00000109424), SLC25A36 (ENSG00000114120), SLC25A12 (ENSG00000115840), SLC25A2 (ENSG00000120329), SLC25A51 (ENSG00000122696), SLC25A16 (ENSG00000122912), SLC25A35 (ENSG00000125434), SLC25A19 (ENSG00000125454), SLC25A23 (ENSG00000125648), SLC25A47 (ENSG00000140107), SLC25A52 (ENSG00000141437), SLC25A38 (ENSG00000144659), SLC25A26 (ENSG00000144741), SLC25A48 (ENSG00000145832), SLC25A37 (ENSG00000147454), SLC25A25 (ENSG00000148339), SLC25A31 (ENSG00000151475), SLC25A4 (ENSG00000151729), SLC25A27 (ENSG00000153291), SLC25A28 (ENSG00000155287), SLC25A44 (ENSG00000160785), SLC25A45 (ENSG00000162241), SLC25A34 (ENSG00000162461), SLC25A32 (ENSG00000164933), SLC25A6 (ENSG00000169100), SLC25A30 (ENSG00000174032), UCP3 (ENSG00000175564), UCP2 (ENSG00000175567)
Protein
Protein identifiers
Solute carrier family 25 member 33 — Q9BSK2 (reviewed: Q9BSK2)
Alternative names: Bone marrow stromal cell mitochondrial carrier protein, Protein PNC1
All UniProt accessions (1): Q9BSK2
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial transporter that imports/exports pyrimidine nucleotides into and from mitochondria. Selectively transports uridine, thymidine, guanosine, cytosine and inosine (deoxy)nucleoside di- and triphosphates by an antiport mechanism. May import (deoxy)nucleoside triphosphates in exchange for intramitochondrial (deoxy)nucleoside diphosphates, thus providing precursors necessary for de novo synthesis of mitochondrial DNA and RNA while exporting products of their catabolism. Participates in mitochondrial genome maintenance, regulation of mitochondrial membrane potential and mitochondrial respiration. Upon INS or IGF1 stimulation regulates cell growth and proliferation by controlling mitochondrial DNA replication and transcription, the ratio of mitochondria-to nuclear-encoded components of the electron transport chain resulting in control of mitochondrial ROS production. Participates in dendritic cell endocytosis and may associate with mitochondrial oxidative phosphorylation.
Subcellular location. Mitochondrion inner membrane.
Tissue specificity. Expressed in the central nervous system. Also expressed in testis and skeletal muscle. Weakly expressed in heart, liver, kidney, prostate, colon and peripheral blood leukocytes.
Activity regulation. Inhibited by pyridoxal 5’-phosphate, 4,7-diphenyl-1,10-phenanthroline, tannic acid, and mercurials (mercury dichloride, mersalyl acid, p-hydroxymercuribenzoate).
Induction. By INS or IGF1 through the PI-3 kinase/mTOR pathway.
Similarity. Belongs to the mitochondrial carrier (TC 2.A.29) family.
RefSeq proteins (1): NP_115691* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018108 | MCP_transmembrane | Repeat |
| IPR023395 | MCP_dom_sf | Homologous_superfamily |
| IPR049562 | SLC25A33/36-like | Family |
Pfam: PF00153
Catalyzed reactions (Rhea), 12 shown:
- UTP(in) + UDP(out) = UTP(out) + UDP(in) (RHEA:73515)
- dUTP(out) + UTP(in) = dUTP(in) + UTP(out) (RHEA:73519)
- 5-methyl-UTP(out) + UTP(in) = 5-methyl-UTP(in) + UTP(out) (RHEA:73523)
- 5-methyl-UDP(out) + UTP(in) = 5-methyl-UDP(in) + UTP(out) (RHEA:73527)
- UTP(in) + CTP(out) = UTP(out) + CTP(in) (RHEA:73531)
- CDP(out) + UTP(in) = CDP(in) + UTP(out) (RHEA:73535)
- dCTP(out) + UTP(in) = dCTP(in) + UTP(out) (RHEA:73539)
- dCDP(out) + UTP(in) = dCDP(in) + UTP(out) (RHEA:73543)
- UTP(in) + GTP(out) = UTP(out) + GTP(in) (RHEA:73547)
- UTP(in) + GDP(out) = UTP(out) + GDP(in) (RHEA:73551)
- dGTP(out) + UTP(in) = dGTP(in) + UTP(out) (RHEA:73559)
- dGDP(out) + UTP(in) = dGDP(in) + UTP(out) (RHEA:73563)
UniProt features (11 total): transmembrane region 6, repeat 3, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BSK2-F1 | 85.41 | 0.63 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 178 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOBP_GROWTH, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, USF_C, GOBP_NUCLEOTIDE_TRANSPORT, GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS, GOBP_CYTOCHROME_COMPLEX_ASSEMBLY, GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, CTCTAGA_MIR526C_MIR518F_MIR526A, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION
GO Biological Process (15): regulation of oxidative phosphorylation (GO:0002082), mitochondrial transcription (GO:0006390), mitochondrion organization (GO:0007005), positive regulation of cell population proliferation (GO:0008284), positive regulation of cell growth (GO:0030307), mitochondria-nucleus signaling pathway (GO:0031930), cellular response to insulin stimulus (GO:0032869), mitochondrial respiratory chain complex III assembly (GO:0034551), regulation of reactive oxygen species biosynthetic process (GO:1903426), cellular response to insulin-like growth factor stimulus (GO:1990314), pyrimidine nucleotide import into mitochondrion (GO:1990519), obsolete mitochondrial genome maintenance (GO:0000002), nucleotide transport (GO:0006862), pyrimidine nucleotide transport (GO:0006864), regulation of mitochondrial membrane potential (GO:0051881)
GO Molecular Function (1): pyrimidine nucleotide transmembrane transporter activity (GO:0015218)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial membrane (GO:0031966), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 3 |
| positive regulation of cellular process | 2 |
| cellular response to peptide hormone stimulus | 2 |
| pyrimidine nucleotide transport | 2 |
| oxidative phosphorylation | 1 |
| regulation of aerobic respiration | 1 |
| mitochondrial RNA metabolic process | 1 |
| DNA-templated transcription | 1 |
| mitochondrial gene expression | 1 |
| organelle organization | 1 |
| cell population proliferation | 1 |
| regulation of cell population proliferation | 1 |
| regulation of cell growth | 1 |
| cell growth | 1 |
| positive regulation of growth | 1 |
| intracellular signal transduction | 1 |
| response to insulin | 1 |
| respiratory chain complex III assembly | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| regulation of biosynthetic process | 1 |
| reactive oxygen species biosynthetic process | 1 |
| regulation of reactive oxygen species metabolic process | 1 |
| intercellular transport | 1 |
| pyrimidine-containing compound transmembrane transport | 1 |
| nucleotide transmembrane transport | 1 |
| organophosphate ester transport | 1 |
| nucleobase-containing compound transport | 1 |
| nucleotide transport | 1 |
| regulation of membrane potential | 1 |
| nucleotide transmembrane transporter activity | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1050 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC25A33 | MTCH1 | Q9NZJ7 | 822 |
| SLC25A33 | MTCH2 | Q9Y6C9 | 770 |
| SLC25A33 | SLC25A52 | Q3SY17 | 568 |
| SLC25A33 | SLC25A53 | Q5H9E4 | 540 |
| SLC25A33 | LZIC | Q8WZA0 | 512 |
| SLC25A33 | GPR157 | Q5UAW9 | 455 |
| SLC25A33 | YME1L1 | Q96TA2 | 444 |
| SLC25A33 | RIMS2 | Q9UQ26 | 431 |
| SLC25A33 | NMNAT1 | Q9HAN9 | 415 |
| SLC25A33 | SLC45A1 | Q9Y2W3 | 415 |
| SLC25A33 | TATDN2 | Q93075 | 413 |
| SLC25A33 | NKX1-1 | Q15270 | 379 |
| SLC25A33 | F6RGN5 | F6RGN5 | 367 |
| SLC25A33 | FASTKD2 | Q9NYY8 | 367 |
| SLC25A33 | B3GALT5 | Q9Y2C3 | 355 |
IntAct
42 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SDF4 | ACAD11 | psi-mi:“MI:0914”(association) | 0.640 |
| SLC1A1 | AGPAT2 | psi-mi:“MI:0914”(association) | 0.640 |
| HLA-DPA1 | TYW5 | psi-mi:“MI:0914”(association) | 0.530 |
| IL13RA2 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| APLNR | SLC33A1 | psi-mi:“MI:0914”(association) | 0.530 |
| NPTN | TNPO2 | psi-mi:“MI:0914”(association) | 0.530 |
| NCEH1 | CLGN | psi-mi:“MI:0914”(association) | 0.530 |
| CCNJL | HSPA5 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC25A33 | YAE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GLMP | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| ATAD3A | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 | |
| MGARP | BTAF1 | psi-mi:“MI:0914”(association) | 0.350 |
| CRELD1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC18A2 | UBXN8 | psi-mi:“MI:0914”(association) | 0.350 |
| CD79A | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
| SGCA | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
| ISLR | psi-mi:“MI:0914”(association) | 0.350 | |
| SLC1A1 | UBXN8 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP2A3 | UBXN8 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC2A1 | SLC33A1 | psi-mi:“MI:0914”(association) | 0.350 |
| HLA-DRA | MGRN1 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM150A | ACSL4 | psi-mi:“MI:0914”(association) | 0.350 |
| KLK1 | CRLF1 | psi-mi:“MI:0914”(association) | 0.350 |
| CD3D | TAP2 | psi-mi:“MI:0914”(association) | 0.350 |
| ACTL6B | SLC25A16 | psi-mi:“MI:0914”(association) | 0.350 |
| CD80 | RIMOC1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (34): SLC25A33 (Co-fractionation), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS), SLC25A33 (Affinity Capture-MS)
ESM2 similar proteins: A0A0G2K309, A0A1D6N272, A3KPP4, G3XP90, G3YD89, O13844, P04575, P04633, P12234, P12242, P16036, P33303, Q08DK7, Q0VCH6, Q1LZB3, Q27257, Q29RM1, Q3KQZ1, Q3TZX3, Q505J6, Q58DS3, Q5HZE0, Q5IS35, Q5NVC1, Q5R7W2, Q5SWT3, Q6AYL0, Q6DFK2, Q6P036, Q6P316, Q7K566, Q8BGP6, Q8BL03, Q8BZ09, Q8N8R3, Q8TBP6, Q8VEM8, Q93XM7, Q99JD3, Q9BSK2
Diamond homologs: A0A0G2K309, A0A0U2IR85, A1DI57, A2Q9F0, A2R5A0, A4RF23, A6RAY2, A6RF73, A6SL61, A7ER02, B0G143, F1LX07, F1LZW6, G3YC86, O13660, O22261, O43808, O60029, O70579, O75746, P0C582, P16261, P25083, P27081, P29518, P32089, P38127, P39953, P40556, P40941, P53007, P55851, P90992, P97521, Q08DK7, Q09188, Q0CEN9, Q0II44, Q0UUH1, Q12482
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
56 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 3 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1873 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:9553620:TTACA:T | acceptor_loss | 1.0000 |
| 1:9553621:TACA:T | acceptor_loss | 1.0000 |
| 1:9553622:ACAGG:A | acceptor_loss | 1.0000 |
| 1:9553623:CAGGT:C | acceptor_loss | 1.0000 |
| 1:9553624:A:AT | acceptor_loss | 1.0000 |
| 1:9553625:GGT:G | acceptor_gain | 1.0000 |
| 1:9553625:GGTGT:G | acceptor_gain | 1.0000 |
| 1:9553803:GAA:G | donor_gain | 1.0000 |
| 1:9553806:G:GG | donor_gain | 1.0000 |
| 1:9567361:GGT:G | donor_loss | 1.0000 |
| 1:9567362:G:GC | donor_loss | 1.0000 |
| 1:9567363:T:A | donor_loss | 1.0000 |
| 1:9573340:TTCCA:T | acceptor_loss | 1.0000 |
| 1:9573341:TCCAG:T | acceptor_loss | 1.0000 |
| 1:9573342:CCAGC:C | acceptor_loss | 1.0000 |
| 1:9573343:CAG:C | acceptor_loss | 1.0000 |
| 1:9573344:A:AG | acceptor_gain | 1.0000 |
| 1:9573344:AGCTT:A | acceptor_loss | 1.0000 |
| 1:9573345:G:GA | acceptor_gain | 1.0000 |
| 1:9573345:G:T | acceptor_loss | 1.0000 |
| 1:9573345:GC:G | acceptor_gain | 1.0000 |
| 1:9573345:GCT:G | acceptor_gain | 1.0000 |
| 1:9573345:GCTT:G | acceptor_gain | 1.0000 |
| 1:9573345:GCTTT:G | acceptor_gain | 1.0000 |
| 1:9573408:CAGAA:C | donor_gain | 1.0000 |
| 1:9573409:AGAA:A | donor_gain | 1.0000 |
| 1:9573410:G:GT | donor_gain | 1.0000 |
| 1:9573410:GAA:G | donor_gain | 1.0000 |
| 1:9573411:AA:A | donor_gain | 1.0000 |
| 1:9573412:AG:A | donor_loss | 1.0000 |
AlphaMissense
2051 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:9567324:G:C | G93R | 0.998 |
| 1:9573388:A:T | K153I | 0.998 |
| 1:9573394:G:C | R155P | 0.998 |
| 1:9582308:G:T | R258M | 0.998 |
| 1:9582317:T:C | L261P | 0.998 |
| 1:9582443:C:A | A303D | 0.998 |
| 1:9570260:C:A | A106D | 0.997 |
| 1:9570268:T:C | F109L | 0.997 |
| 1:9570269:T:C | F109S | 0.997 |
| 1:9570270:T:A | F109L | 0.997 |
| 1:9570270:T:G | F109L | 0.997 |
| 1:9570347:C:A | A135D | 0.997 |
| 1:9573389:A:C | K153N | 0.997 |
| 1:9573389:A:T | K153N | 0.997 |
| 1:9580036:G:A | G189R | 0.997 |
| 1:9580036:G:C | G189R | 0.997 |
| 1:9580046:C:A | A192D | 0.997 |
| 1:9582308:G:C | R258T | 0.997 |
| 1:9582320:G:C | R262P | 0.997 |
| 1:9582403:G:A | G290R | 0.997 |
| 1:9582403:G:C | G290R | 0.997 |
| 1:9582404:G:A | G290E | 0.997 |
| 1:9553643:G:A | G25D | 0.996 |
| 1:9553677:G:C | K36N | 0.996 |
| 1:9553677:G:T | K36N | 0.996 |
| 1:9570259:G:C | A106P | 0.996 |
| 1:9573403:T:C | L158P | 0.996 |
| 1:9580037:G:A | G189E | 0.996 |
| 1:9580190:C:A | A240D | 0.996 |
| 1:9582314:G:C | R260T | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000087092 (1:9582165 C>T), RS1000099130 (1:9540788 T>C), RS1000124836 (1:9569193 C>G), RS1000278719 (1:9570699 A>G,T), RS1000292175 (1:9551452 G>A), RS1000320329 (1:9539941 C>A,T), RS1000413744 (1:9546324 A>G), RS1000425272 (1:9568912 C>T), RS1000477915 (1:9575569 C>G), RS1000525467 (1:9564281 G>A), RS1000613387 (1:9545577 A>G), RS1000636974 (1:9557993 A>G), RS1000733238 (1:9558254 A>G), RS1000750633 (1:9551706 C>A,T), RS1000822465 (1:9558711 T>G)
Disease associations
OMIM: gene MIM:610816 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007096_27 | Pulse pressure | 4.000000e-10 |
| GCST007099_56 | Systolic blood pressure | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0006335 | systolic blood pressure |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Mitochondrial nucleotide transporter subfamily
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression, increases expression | 3 |
| Aflatoxin B1 | affects expression, decreases expression | 3 |
| Leflunomide | increases expression | 2 |
| Air Pollutants | increases abundance, increases expression, decreases expression | 2 |
| Arsenic | increases abundance, increases expression, affects methylation | 2 |
| Benzo(a)pyrene | decreases expression | 2 |
| Estradiol | affects cotreatment, decreases expression, increases expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Tretinoin | decreases expression | 2 |
| Valproic Acid | increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| GSK-J4 | increases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| methyleugenol | decreases expression | 1 |
| pirinixic acid | affects binding, increases activity, increases expression | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| K 7174 | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Plant Oils | increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4JX | HCT116-SLC25A33-KO-c25 | Cancer cell line | Male |
| CVCL_D4JY | HCT116-SLC25A33-KO-c7 | Cancer cell line | Male |
| CVCL_TM34 | HAP1 SLC25A33 (-) 1 | Cancer cell line | Male |
| CVCL_TM35 | HAP1 SLC25A33 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.